A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy

DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a scientific paper from GenKOre on the new hypercompact CRISPR system called CRISPR/Cas12f-GE was published in an online

Related Keywords

Daejeon ,Taejon Gwangyoksi ,South Korea ,South Korean ,Yong Sam Kim ,Kostenloser Wertpapierhandel ,Korea Research Institute Of Bioscience Biotechnology ,Nature Biotechnology ,Adeno Associated Virus ,Korea Research Institute ,Hypercompact ,Rispr ,Technology ,Eveloped ,Genkore ,Neemed ,Potential ,Name ,Hanger ,Gene ,Therapy ,